Am J Physiol Endocrinol Metab 319(6):E1019E1030
Ozempic is licensed for patients with type 2 diabetes to control blood sugar levels
The market opportunity in obesity is significant considering the high prevalence and associated health complications, which include type 2 diabetes (T2D), cardiovascular diseases (CVD), sleep apnea, chronic kidney disease (CKD), certain cancers, and an increased risk of death
Supplied as an analytical reference for in vitro and laboratory research
Epithalon is a synthetic tetrapeptide with the following amino acid makeup: alanine, glutamic acid, aspartic acid, and glycine
These interactions can change how well a medicine works, increase side effects, or cause unexpected reactions